A detailed history of American Capital Management Inc transactions in Haemonetics Corp stock. As of the latest transaction made, American Capital Management Inc holds 80,295 shares of HAE stock, worth $6.87 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
80,295
Previous 80,995 0.86%
Holding current value
$6.87 Million
Previous $6.93 Million 1.04%
% of portfolio
0.22%
Previous 0.24%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$71.24 - $85.35 $49,868 - $59,744
-700 Reduced 0.86%
80,295 $6.85 Million
Q4 2022

Feb 14, 2023

SELL
$73.85 - $86.14 $590,800 - $689,120
-8,000 Reduced 8.99%
80,995 $6.37 Million
Q3 2022

Nov 14, 2022

SELL
$63.3 - $78.66 $601,350 - $747,270
-9,500 Reduced 9.65%
88,995 $6.59 Million
Q2 2022

Aug 15, 2022

SELL
$49.27 - $66.08 $24,635 - $33,040
-500 Reduced 0.51%
98,495 $6.42 Million
Q1 2022

May 16, 2022

SELL
$43.77 - $63.22 $569,010 - $821,860
-13,000 Reduced 11.61%
98,995 $6.26 Million
Q4 2021

Feb 14, 2022

SELL
$49.55 - $74.59 $1.41 Million - $2.13 Million
-28,500 Reduced 20.29%
111,995 $5.94 Million
Q3 2021

Nov 15, 2021

SELL
$57.6 - $70.59 $619,200 - $758,842
-10,750 Reduced 7.11%
140,495 $9.92 Million
Q2 2021

Aug 13, 2021

SELL
$51.81 - $118.56 $103,620 - $237,120
-2,000 Reduced 1.31%
151,245 $10.1 Million
Q4 2020

Feb 16, 2021

SELL
$88.75 - $119.95 $79,875 - $107,955
-900 Reduced 0.58%
153,245 $18.2 Million
Q3 2020

Nov 16, 2020

SELL
$75.65 - $93.58 $378,250 - $467,900
-5,000 Reduced 3.14%
154,145 $13.4 Million
Q1 2020

May 15, 2020

BUY
$74.34 - $121.82 $36,798 - $60,300
495 Added 0.31%
159,145 $15.9 Million
Q4 2019

Feb 12, 2020

SELL
$114.37 - $129.46 $9,721 - $11,004
-85 Reduced 0.05%
158,650 $18.2 Million
Q2 2019

Aug 12, 2019

SELL
$81.74 - $120.34 $204,350 - $300,850
-2,500 Reduced 1.55%
158,735 $19.1 Million
Q1 2019

May 14, 2019

SELL
$83.25 - $102.12 $5.56 Million - $6.82 Million
-66,765 Reduced 29.28%
161,235 $14.1 Million
Q4 2018

Feb 08, 2019

SELL
$90.66 - $116.63 $562,092 - $723,106
-6,200 Reduced 2.65%
228,000 $22.8 Million
Q2 2018

Jul 17, 2018

SELL
$71.53 - $95.75 $586,546 - $785,150
-8,200 Reduced 3.38%
234,200 $21 Million
Q1 2018

Apr 23, 2018

SELL
$60.72 - $74.41 $10.9 Million - $13.3 Million
-178,896 Reduced 42.46%
242,400 $17.7 Million
Q4 2017

Apr 05, 2018

BUY
$44.96 - $58.99 $17,984 - $23,596
400 Added 0.1%
421,296 $24.5 Million
Q4 2017

Jan 23, 2018

SELL
$44.96 - $58.99 $296,736 - $389,334
-6,600 Reduced 1.54%
420,896 $24.4 Million
Q3 2017

Apr 05, 2018

BUY
$40.38 - $44.87 $16,152 - $17,948
400 Added 0.09%
427,496 $19.2 Million
Q3 2017

Oct 20, 2017

SELL
$40.38 - $44.87 $496,674 - $551,901
-12,300 Reduced 2.8%
427,096 $19.2 Million
Q2 2017

Apr 19, 2018

SELL
N/A
-94,400 Reduced 17.68%
439,396 $17.4 Million
Q1 2017

Apr 18, 2018

BUY
N/A
533,796
533,796 $21.7 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.39B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track American Capital Management Inc Portfolio

Follow American Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Capital Management Inc with notifications on news.